07 Jan 2001

Estragest TTS® (Estragest TTS® Transdermales Pflaster) - Deutschland

Updated: 07 Jan 2001

Estragest TTS®

Behandl. v. Beschwerden u. Symptomen des Östrogenmangels wie z. B. Hitzewallungen, Schlafstörungen, Urogenitalatrophie u. begleitende depress. Verstimmungen. Estragest TTS wird eingesetzt bei Pat. m. intaktem Uterus, die mind. 2 J. postmenopausal sind.

Estragest TTS® Description, Presentation and Dosage

Estragest TTS® Description

Estragest TTS® Drug Class Description

Östrogene u. Gestagene ohne andere Stoffe

Estragest TTS® Drug Description

1 Transdermales Pflaster enth.: Estradiol ½H2O 5,17 mg (entspr. 5 mg Estradiol), (nominelle Estradiol-Abgaberate 25 µg/Tag), Norethisteronacetat 15 mg (nominelle Norethisteronacetat-Abgaberate 125 µg/Tag), Abgabefläche 10 cm2.

Estragest TTS® Generic Name

Estragest TTS® Transdermales Pflaster

Estragest TTS® Presentation

Estragest TTS® Presentation

Estragest TTS®

Estragest TTS® Manufacturer

Novartis Pharma

Related Learning Zones

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

G.MKT.GM.MH.01.2016.0364

Cystic Fibrosis Knowledge Centre

Cystic Fibrosis Knowledge Centre

Cystic fibrosis (CF) is a genetic condition caused by a defect in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. The Cystic Fibrosis Knowledge Centre provides healthcare professionals with access to disease awareness information, emerging and established treatment options and current best practice based on recently updated guidelines by the European Cystic Fibrosis Society (ECFS). A resources section contains external links to upcoming medical conferences and patient support groups.

This resource is developed by EPG Health Media for epgonline.org, supported by an independent educational grant from Vertex.

Estragest TTS® Dosage

Estragest TTS® Adult Dosage

Ethanol, Hydroxypropylcellulose, Pegoterat, Poly-(ethylen-co-vinylacetat), flüssiges Paraffin, Polyisobutylen, Silikonbeschichtung auf der Innenseite der Schutzfolie (wird vor Anw. des Pflasters entfernt).

Estragest TTS® Precautions, Reactions and Contraindications

Estragest TTS® Special Precautions

Estragest TTS® Special Precautions

G 5 a, f, O 6 a, b. Porphyrie. Aktive tiefe Venenthrombose od. thromboembol. Erkrank. (auch in der Anamnese).

Estragest TTS® Adverse Reactions

Estragest TTS® Adverse Reactions

Kontraind..

Related Drugs - Sexual Health

Back to top